The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care

Applications for Gatra 2026 will be accepted between 01/11/2025 and 31/05/2026

Please click here to apply.

To see the 2025 GATRA Award winner please click here.